Search

Search Constraints

You searched for: Author/Creator McKeever, Paul

Search Results

3. ATIM-44. A PHASE I FIRST-IN-HUMAN TRIAL OF TWO ADENOVIRAL VECTORS EXPRESSING HSV1-TK AND FLT3L FOR TREATING NEWLY DIAGNOSED RESECTABLE MALIGNANT GLIOMA: THERAPEUTIC REPROGRAMMING OF THE BRAIN IMMUNE SYSTEM. (11th November 2019)

8. Correlation of the ratio of metallic to oxide species with activity of PdPt catalysts for methane oxidation. Issue 5 (31st January 2020)

9. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. Issue 8 (6th February 2018)

10. First in Human Phase I Trial of Dual Vector (HSV1-TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High-Grade Glioma: Initial Results. (1st September 2019)